Axon Neuroscience's active tau immunotherapy AADvac1 has been selected as the first tau-targeted therapy to enter a ...

Because many different types of cancer cells overexpress programmed death-ligand 1 (PD-L1), this cell surface protein is a major target of cancer immunotherapy. Unfortunately, drugs that target it do ...

RMAT designation requires preliminary clinical evidence addressing an unmet need in a serious disease and provides Fast Track ...

New research suggests cancer immunotherapy may work better when given earlier in the day. In a randomized lung cancer study, ...

A new randomized clinical trial showed that receiving immunochemotherapy infusions earlier in the day may help patients with ...

A UCLA research team has identified the best design for a promising new type of immunotherapy that could be mass-produced to ...

Investigators analyzed economic evaluations of adjuvant immunotherapy to assess cost-effectiveness outcomes, quality-adjusted life-year (QALY)/life-year (LY) gains, and methodologic approaches.

Share on Pinterest The novel AI-ready database could help to accelerate cancer immunotherapy research. Image credit: Assembly/Getty Images The Cancer Research Institute (CRI) launches a ...

Cancer immunotherapy has been a game-changer, but many tumors still find ways to slip past the immune system. New research reveals a hidden trick: cancer cells can package the immune-blocking protein ...

The University of California, Los Angeles (UCLA) has received a $120 million commitment to support the recently established California Institute for Immunology and Immunotherapy, positioning the ...

From cell-manufacturing laboratories to outpatient infusion facilities, health systems are rapidly adapting to a new kind of cancer treatment that demands individualized care, infrastructure and ...

Allergic rhinitis is an inflammatory disorder of the nasal mucosa, predominantly triggered by airborne allergens such as pollen, dust mite, and mould spores. Marked by symptoms including sneezing, ...